OPEN END TURBO BULL OPTIONSSCHEIN - IPSEN | Real-time BOERSE MUENCHEN 08:45:45 31/05/2024 BST | ||
| 1.2 EUR | +1.69% |
|
| Current month | +51.28% | ||
| 1 month | +51.28% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Chart
IPSEN
| Date | Price | Change |
|---|---|---|
| 31/05/24 | 1.2 | +1.69% |
| 30/05/24 | 1.18 | -4.84% |
| 29/05/24 | 1.24 | +2.48% |
| 28/05/24 | 1.21 | -8.33% |
| 27/05/24 | 1.32 | -12.00% |
Real-time BOERSE MUENCHEN
Last update May 31, 2024 at 08:45 am
More quotesStatic data
| Product type | Knock-Out without Stop Loss |
|---|---|
| Buy / Sell | CALL |
| Underlying | IPSEN |
| Issuer | 
UniCredit
|
| WKN | HD515B |
| ISIN | DE000HD515B4 |
| Date issued | 25/04/2024 |
| Strike | 109.8 € |
| Maturity | Unlimited |
| Parity | 10 : 1 |
| Emission price | 0.74 € |
| Emission volume | N/A |
| Settlement | cash |
| Currency | EUR |
Technical Indicators
| Highest since issue | 1.57 € |
|---|---|
| Lowest since issue | 0.64 € |
| Spread | 0.05 € |
| Spread % | 3.97% |
Company Profile
Ipsen specialises in the research, development, manufacture and marketing of specialty medicines. Net sales by therapeutic area break down as follows:
- oncology (75.2%);
- neuroscience (21.1%);
- rare diseases (3.7%).
At the end of 2023, the group had 4 research and development centres located in France, the United Kingdom, the United States and China, and 4 manufacturing sites worldwide.
Net sales are distributed geographically as follows: Europe (40.2%), North America (33.3%) and other (26.5%).
Sector
-
Consensus: Ipsen
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
16
Last Close Price
119.4
EUR
Average target price
126.4
EUR
Spread / Average Target
+5.86%
- Stock Market
- Certificates
- Certificat
